HuGE Literature Finder
Records
1
-
8
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Miguel Sánchez José, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
| Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer. Cancer letters 2019 Feb 442 53-67. Zhang Panpan, Kang Bin, Xie Guoyun, Li Shaolei, Gu Ying, Shen Yue, Zhao Xin, Ma Yuanyuan, Li Fuqiang, Si Jiahui, Wang Jian, Chen Jinfeng, Yang Huanming, Xu Xun, Yang Y |
| Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients. BMC cancer 2016 Nov 16 (1): 864. Ko Ryo, Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Wakuda Kazushige, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Isaka Mitsuhiro, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyuki, Takahashi Kazuhisa, Takahashi Toshia |
| FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib. Cancer science 2016 Sep . Hibi Masaaki, Kaneda Hiroyasu, Tanizaki Junko, Sakai Kazuko, Togashi Yosuke, Terashima Masato, De Velasco Marco Antonio, Fujita Yoshihiko, Banno Eri, Nakamura Yu, Takeda Masayuki, Ito Akihiko, Mitsudomi Tetsuya, Nakagawa Kazuhiko, Okamoto Isamu, Nishio Kazu |
| Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study. Cancer 2014 May 120 (10): 1471-81. Serizawa Masakuni, Koh Yasuhiro, Kenmotsu Hirotsugu, Isaka Mitsuhiro, Murakami Haruyasu, Akamatsu Hiroaki, Mori Keita, Abe Masato, Hayashi Isamu, Taira Tetsuhiko, Maniwa Tomohiro, Takahashi Toshiaki, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyu |
| Molecular profiling of small cell lung cancer in a Japanese cohort. Lung cancer (Amsterdam, Netherlands) 2014 May 84 (2): 139-44. Wakuda Kazushige, Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Isaka Mitsuhiro, Takahashi Shoji, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Mori Keita, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Takahashi Toshiaki, Yamamoto Nobuyu |
| Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays. BMC cancer 2014 14 786. Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Isaka Mitsuhiro, Takahashi Toshiaki, Taira Tetsuhiko, Ono Akira, Maniwa Tomohiro, Takahashi Shoji, Mori Keita, Endo Masahiro, Abe Masato, Hayashi Isamu, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyu |
| A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013 Jan 8 (1): 79-88. Dy Grace K, Mandrekar Sumithra J, Nelson Garth D, Meyers Jeffrey P, Adjei Araba A, Ross Helen J, Ansari Rafat H, Lyss Alan P, Stella Philip J, Schild Steven E, Molina Julian R, Adjei Alex |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 01, 2023
- Content source: